| 251 |
Concomitant Adjuvant Chemotherapy (Florouracil, Epirubicin and Cyclophosphamide) and Post-operative Radiotherapy in Upper Egyptian Patients with Respectable T3 and T4 Breast Carcinoma. |
1997 |
| 252 |
Concomitant Boost Accelerated Radiation Therapy for Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx. |
1997 |
| 253 |
Evaluation of the Efficacy and Toxicity of Florouracil and Leucovorin (5-FU/LV) with Pelvic Irradiation as Adjuvant Therapy for Patients with Resected Rectal Cancer. |
1997 |
| 254 |
Feasibility of Accelerated Fractionation Radiation, Concurrent with 5-Fluorouracil (5-FU) and Cisplatin (CDDP) for Locally Advanced Esophageal Cancer. |
1997 |
| 255 |
The Role of Radioiodine and Technetium-99m Sestamibi in the Evaluation of Patients with Differentiated Thyroid Cancer after Surgery. |
1997 |
| 256 |
Tamoxafin in Patients with Advanced Epithelial Ovarian Carcinoma. |
1996 |
| 257 |
Prognostic Significance of Serum Laminin P1 in Conjunction with PSA in Cancer Prostate. |
1994 |
| 258 |
FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients |
|
| 259 |
FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients |
|
